Tag Archives: CDEV

Top Clean Energy Stocks To Own Right Now

Toward the end of trading Tuesday, the Dow traded up 0.49 percent to 24,370.33 while the NASDAQ climbed 0.85 percent to 7,596.27 . The S&P also rose, gaining 0.54 percent to 2,731.75 .

Leading and Lagging Sectors

Tuesday afternoon, the energy shares surged 1.1 percent. Meanwhile, top gainers in the sector included NextDecade Corporation (NASDAQ: NEXT) up 10 percent, and Clean Energy Fuels Corp. (NASDAQ: CLNE) up 9 percent.

In trading on Tuesday, telecommunication services shares fell 0.76 percent.

Top Headline

Lennar Corporation (NYSE: LEN) reported better-than-expected results for its fiscal second quarter.

Lennar said it earned $1.58 per share in the quarter on revenue of $5.459 billion versus expectations of 45 cents and $5.1 billion.

 

Equities Trading UP

TSR, Inc. (NASDAQ: TSRI) shares shot up 37 percent to $8.30 after James Hughes requested TSR pursue a sale of the company.

Shares of Lee Enterprises, Incorporated (NYSE: LEE) got a boost, shooting up 27 percent to $3.05. The provider of local news and information, and a major platform for advertising said it reached an agreement to manage Berkshire Hathaway's newspaper and digital operations in 30 markets.

Top Clean Energy Stocks To Own Right Now: Centennial Resource Development, Inc. (CDEV)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Centennial Resource Development (NASDAQ:CDEV) is already up 90% since new management took the reins in 2016. But that could be just the beginning of its run. That’s because the executive team quickly scooped up drillable land in the Permian Basin, locking up a prime position in the heart of the oil-rich shale play. That position, along with the company’s best-in-class balance sheet, has enabled it to unleash a gusher of oil in the past year, with even more on the way. And that fast-growing output, when combined with rising oil prices and falling costs, positions the company to generate significant earnings growth as the oil market continues its recovery.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Centennial Resource Dev (CDEV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    BidaskClub upgraded shares of Centennial Resource Development (NASDAQ:CDEV) from a sell rating to a hold rating in a research note issued to investors on Thursday morning.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Centennial Resource Development (CDEV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Clean Energy Stocks To Own Right Now: S&P Smallcap 600(PH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Parker Hannifin (PH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System reduced its position in Parker Hannifin (NYSE:PH) by 3.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,950 shares of the industrial products company’s stock after selling 6,667 shares during the period. State Board of Administration of Florida Retirement System owned approximately 0.13% of Parker Hannifin worth $29,580,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Barings LLC decreased its holdings in Parker Hannifin (NYSE:PH) by 36.4% in the first quarter, HoldingsChannel reports. The firm owned 26,064 shares of the industrial products company’s stock after selling 14,937 shares during the period. Barings LLC’s holdings in Parker Hannifin were worth $4,458,000 as of its most recent SEC filing.

Top Clean Energy Stocks To Own Right Now: Ellington Residential Mortgage REIT(EARN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ellington Residential (NYSE:EARN) major shareholder Holdings L.P. Blackstone III bought 11,909 shares of Ellington Residential stock in a transaction that occurred on Monday, May 14th. The stock was purchased at an average cost of $11.26 per share, for a total transaction of $134,095.34. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Top Clean Energy Stocks To Own Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of DBV Technologies (NASDAQ:DBVT) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.00.

  • [By Max Byerly]

    Shares of DBV Technologies (NASDAQ:DBVT) hit a new 52-week low on Tuesday . The stock traded as low as $20.00 and last traded at $20.31, with a volume of 2187 shares trading hands. The stock had previously closed at $20.07.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DBV Technologies (DBVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy For 2019

The staffing industry – and the IT staffing industry in particular – is poised for tremendous growth in the foreseeable future, and that rising tide bodes very well for Staffing 360 Solutions Inc. (NASDAQ:STAF).

For those who’ve followed the sociopolitical rhetoric it would be easy to conclude what job growth we’ve seen in the past few years has been measly, made even less impressive by the fact most of the new jobs have been less-than-great-career types of jobs. And to be fair, there’s a kernel of truth in what the critics are saying. A closer inspection is merited though, because a closer look clarifies that some industries are seeing tremendous job growth. One of the hottest hot spots? You guessed it … IT jobs.

According to the Bureau of Labor Statistics, software and developer positions will grow by 19% between 2014 and 2024, making it one of the nation’s fastest-growing non-medical career choices. When you broaden the data out to “computer and mathematical occupations”, the ten-year growth projection is 13.1%, which IS the second-highest growth pace among all jobs (second only to healthcare).

Top 10 Medical Stocks To Buy For 2019: ImmuCell Corporation(ICCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.

Top 10 Medical Stocks To Buy For 2019: Centennial Resource Development, Inc. (CDEV)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)

Top 10 Medical Stocks To Buy For 2019: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

Top 10 Medical Stocks To Buy For 2019: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

Top 10 Medical Stocks To Buy For 2019: Houston Wire & Cable Company(HWCC)

Advisors’ Opinion:

  • [By Max Byerly]

    Houston Wire & Cable (NASDAQ:HWCC) hit a new 52-week high and low during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as low as $8.40 and last traded at $8.35, with a volume of 604 shares traded. The stock had previously closed at $7.90.

Top 10 Medical Stocks To Buy For 2019: Hanwha Q CELLS Co., Ltd. (HQCL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday.
    Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday.
    Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

Top 10 Medical Stocks To Buy For 2019: Express-1 Expedited Solutions Inc.(XPO)

Advisors’ Opinion:

  • [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]

    Yet finding the best stocks to buy and hold isn’t easy. So to help get you started, we asked three Foolish investors to pick a growth stock that they believe investors would be wise to buy now and hold for the long term. Read on to learn why they like SunPower (NASDAQ:SPWR), salesforce.com (NYSE:CRM), and XPO Logistics (NYSE:XPO).

  • [By Jeremy Bowman]

    ARecode article in December made waves when it asserted that Home Depot was considering acquiringXPO Logistics(NYSE:XPO), the U.S. leader in last-mile delivery of heavy goods like furniture and appliances. Home Depot already has a close relationship with XPO, naming it its Mid-Size Truckload Carrier of the year in 2015, and was reportedly interested in acquiring it in part to keep it out of the hands of Amazon, which has been ramping up efforts to sell products like furniture, and is also an XPO customer.

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Thursday’s trending stocks from the floor of the New York Stock Exchange including Macy’s (M) , Amazon (AMZN) , Etsy (ETSY) , XPO Logistics (XPO) and Groupon (GRPN) . 

  • [By Logan Wallace]

    XPO Logistics (NYSE:XPO)‘s stock had its “buy” rating reissued by research analysts at Bank of America in a research note issued on Friday. They presently have a $105.00 target price on the transportation company’s stock. Bank of America’s price objective would indicate a potential upside of 4.86% from the stock’s previous close.

Top 10 Medical Stocks To Buy For 2019: US Foods Holding Corp. (USFD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Discovery, Inc. (NASDAQ: DISCA) to report quarterly earnings at $0.44 per share on revenue of $1.99 billion before the opening bell. Discovery shares rose 0.47 percent to $23.50 in pre-market trading.
    Analysts expect Marriott International, Inc. (NASDAQ: MAR) to post quarterly earnings at $1.22 per share on revenue of $5.72 billion after the closing bell. Marriott shares gained 0.08 percent to $136.75 in pre-market trading.
    Veeco Instruments Inc. (NASDAQ: VECO) reported stronger-than-expected earnings for its first quarter. Veeco Instruments shares surged 14.04 percent to $19.50 in the after-hours trading session.
    Before the markets open, DISH Network Corporation (NASDAQ: DISH) is projected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion. DISH shares gained 1.53 percent to close at $33.90 on Monday.
    Analysts are expecting US Foods Holding Corp. (NYSE: USFD) to have earned $0.32 per share on revenue of $5.98 billion in the latest quarter. US Foods will release earnings before the markets open. US Foods shares rose 0.57 percent to close at $33.72 on Monday.
    Snap Inc (NYSE: SNAP) disclosed that its CFO Andrew Vollero will leave the company and Amazon.com's VP Of Finance Tim Sloan will assume the role. Snap shares gained 1.3 percent to $10.88 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o

Top 10 Medical Stocks To Buy For 2019: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By ]

    Teva Pharmaceuticals (TEVA) : “No, Teva isn’t good enough. We need growth and yield, and they don’t have it.”

    Chicago Mercantile Exchange (CME) : “That’s an ideal stock for this market. I like the choice.”

  • [By Chris Lange]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its most recent quarterly report before the markets opened on Thursday. The pharma giant said that it had $0.94 in earnings per share (EPS) on $5.1 billion in revenue. Consensus estimates had called for $0.66 in EPS on $4.8 billion in revenue. The same period of last year had $1.06 in EPS on $5.63 billion in revenue.

  • [By Dan Caplinger]

    The stock market posted small advances on Monday, with most major benchmarks picking up between 0.4% and 0.8%. Much of the attention on Wall Street centered on other financial markets, which included favorable price action in oil, a surge in the value of the U.S. dollar against many foreign currencies, and relatively weak performance from gold. Yet there was still plenty of good news that sent individual companies’ shares higher. Teva Pharmaceutical Industries (NYSE:TEVA), Gramercy Property Trust (NYSE:GPT), and Medtronic (NYSE:MDT) were among the best performers on the day. Here’s why they did so well.

Top 10 Medical Stocks To Buy For 2019: ClearBridge Energy MLP Total Return Fund Inc.(CTR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Logan Wallace]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.